Breast cancer specialist discusses treatment advances

1

Harold J. Burstein, MD, PhD, a Dana-Farber breast cancer specialist, discusses some of the important studies presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.

The five-day meeting includes more than 1,000 scientific presentations, seminars, and posters, with a focus on emerging treatments in hard-to-treat populations, patients with metastatic breast cancer, and breast cancer prevention and risk.

Around 8,000 breast cancer experts from 90 countries are attending the symposium to learn about the latest developments in breast cancer care and research.

Comments Sort By Newest

One thought on “Breast cancer specialist discusses treatment advances

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Latest Tweets

Dana-Farber @danafarber
Cancer Conversation's - #BRCA Testing and Genetic Risk https://t.co/FxB1SrKVmC #bcsm https://t.co/0rIkeSu4jw
Dana-Farber @danafarber
Extending Your Bloodline Without Kids - https://t.co/4CelsjD4lL
Dana-Farber @danafarber
RT @NCIResearchCtr: Immunogenicity of therapeutic recombinant immunotoxins https://t.co/aGdrF4jYKx #CancerImmunotherapyMonth https://t.co/6

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.